On Tuesday, Soleno Therapeutics Inc (NASDAQ: SLNO) was 8.41% up from the session before settling in for the closing price of $45.91. A 52-week range for SLNO has been $41.50 – $90.32.
Healthcare Sector giant saw their annual sales surged by 20.19% over the last five years. When this article was written, the company’s average yearly earnings per share was at 104.23%. With a float of $49.25 million, this company’s outstanding shares have now reached $53.70 million.
Soleno Therapeutics Inc (SLNO) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Soleno Therapeutics Inc stocks. The insider ownership of Soleno Therapeutics Inc is 8.30%, while institutional ownership is 117.12%. The most recent insider transaction that took place on Aug 11 ’25, was worth 110,696,581. Before that another transaction happened on Jul 01 ’25, when Company’s insider sold 3,830 for $82.76, making the entire transaction worth $316,971. This insider now owns 13,206 shares in total.
Soleno Therapeutics Inc (SLNO) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -1.27 earnings per share (EPS) during the time that was less than consensus figure (set at -1.08) by -0.19. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.69 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 104.23% per share during the next fiscal year.
Soleno Therapeutics Inc (NASDAQ: SLNO) Trading Performance Indicators
You can see what Soleno Therapeutics Inc (SLNO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 15.88. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 27.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.84, a number that is poised to hit 0.61 in the next quarter and is forecasted to reach 4.06 in one year’s time.
Technical Analysis of Soleno Therapeutics Inc (SLNO)
Analysing the last 5-days average volume posted by the [Soleno Therapeutics Inc, SLNO], we can find that recorded value of 1.69 million was better than the volume posted last year of 1.4 million. As of the previous 9 days, the stock’s Stochastic %D was 44.64%.
During the past 100 days, Soleno Therapeutics Inc’s (SLNO) raw stochastic average was set at 16.43%, which indicates a significant decrease from 88.75% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.13 in the past 14 days, which was lower than the 3.63 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $58.56, while its 200-day Moving Average is $66.96. Now, the first resistance to watch is $51.46. This is followed by the second major resistance level at $53.14. The third major resistance level sits at $55.98. If the price goes on to break the first support level at $46.94, it is likely to go to the next support level at $44.10. Should the price break the second support level, the third support level stands at $42.42.
Soleno Therapeutics Inc (NASDAQ: SLNO) Key Stats
There are 53,710K outstanding shares of the company, which has a market capitalization of 2.67 billion. As of now, sales total 0 K while income totals -175,850 K. Its latest quarter income was 66,020 K while its last quarter net income were 26,010 K.
